重视合并肝切除在肝门胆管癌根治术中的地位
被引量:7
摘要
肝门部胆管癌(hilarcholan舀ocarcinoma)是指发生于胆囊管开口以上的肝总管及左右肝管的胆管癌,约占胆管癌的60%~70%,好发于50—70岁的中老年人。因Klatskin0lJ首先对胆管分叉部腺癌的病理特点进行描述,故又将肝门部胆管癌称为Klatskin瘤。肝门部胆管癌具有侵犯邻近肝脏、周围血管及神经,并发生淋巴结转移的特点,手术切除困难。手术切除是最有效和首选的治疗方法,而切缘无瘤是改善患者远期预后的重要因素。
出处
《中华普通外科杂志》
CSCD
北大核心
2013年第11期817-818,共2页
Chinese Journal of General Surgery
参考文献17
-
1Klatskin G.Adenocarcinoma of the hepatic duct at its bifurcationwithin the portahepatis.An unusual tumor with distinctiveclinical and pathological features.Am J Med,1965,38:241-256.
-
2Capussotti L,Vigano L,Ferrero A,et al.Local surgicalresection of hilar cholangiocarcinoma:is there still a place? HPB(Oxford),2008,10:174-178.
-
3Ikeyama T,Nagino M,Oda K,et al.Surgical approach tobismuth Type I and II hilar cholangiocarcinoma:audit of 54consecutive cases.Ann Surg,2007,246:1052-1057.
-
4Lim JH,Choi GH,Choi SH,et al.Liver resection for Bismuthtype I and Type II hilar cholangiocarcinoma.World J Surg,2013,37:829-837.
-
5Lau SH,Lau WY.Current therapy of hilar cholangiocarcinoma.Hepatobiliary Pancreat Dis Int,2012,11:12-17.
-
6Jamagin WR,Fong Y,DeMatteo RP,et al.Staging,resectability,and outcome in 225 patients with hilar cholangiocarcinoma.AnnSurg,2001,234:507-517.
-
7Tsao JI,Nimura Y,Kamiya J,et al.Management of hilarcholangiocarcinoma:comparison of an American and a Japaneseexperience.Ann Surg,2000,232:166-174.
-
8Lai EC,Lau WY.Aggressive surgical resection for hilarcholangiocarcinoma.ANZ J Surg,2005,75:981-985.
-
9Matsuo K,Rocha FG,Ito K,et al.The Blumgart preoperativestaging system for hilar cholangiocarcinoma:analysis ofresectability and outcomes in 380 patients.J Am Coll Surg,2012,215:343-355.
-
10Neuhaus P,Thelen A,Jonas S,et al.Oncological superiority ofhilar en bloc resection for the treatment of hilarcholangiocarcinoma.Ann Surg Oncol,2012,19:1602-1608.
同被引文献45
-
1曹利平,蒋达峰,彭淑牖.肝叶切除术在肝门胆管癌手术中应用的价值[J].中华普通外科杂志,2006,21(3):161-163. 被引量:5
-
2Dumitrascu T, Chirita D, Ionescu M, et al. Resection for hilar cholangiocarcinoma : analysis of prognostic factors and the impact of systemic inflammation on long-term outcome[J]. J Gastrointest Surg, 2013,17(5) :913-924.
-
3Qiu J, Chen S, Pankaj P, Wu H. Portal Vein Arterializatinn as a Bridge Procedure Against Acute Liver Failure After Extended Hepatectomy for Hilar Cholangiocarcinoma [ J ]. Surg Innov, 2013,21 (4) :372-375.
-
4Hirano S, Kondo S, Tanaka E, et al. Outcome of surgical treatment of hilar cholangiocarcinoma: a special reference to postoperative morbidity and mortality [ J ]. J Hepatobiliary Pancreat Sci. 2010.17(4):455-462.
-
5Cho MS, Kim SH, Park SW, et ai. Surgical outcomes and predicting factors of curative resection in patients with hilar cholangiocarcinoma : 10-year single-institution experience [ J ]. J Gastrointest Surg, 2012,16(9) :1672-1679.
-
6Kawasaki S, Imamura H, Kobayashi A, et al. Results of surgical resection for patients with hilar bile duct cancers:application of extended hepatectomy after biliary drainage and hemihepatic portal vein embolization[ J]. Ann Surg, 2003,238:84-92.
-
7Makuuchi M, Thai BL, Takayasu K, et al. Preoperative portal embolization to increase safety of major hepatectomy for hilar bile duct carcinoma: a preliminary report [ J ]. Surgery, 1990,107 : 521-527.
-
8Schnitzbauer AA, Lang SA, Goessmann H, et al. Right portal vein ligation combined with in situ splitting induces rapid left lateral liver lobe hypertrophy enabling 2-staged extended right hepatic resection in small-for-size settings[ J]. Ann Surg, 2012, 255 ( 3 ) :405-414.
-
9Schadde E, Ardiles V, Robles-Campos R, et al. Early survival and safety of ALPPS: first report of the international ALPPS registry[J]. Ann Surg, 2014,260(5) :836-838.
-
10Petrowsky H,Gyori G, de Oliveira M, et al. Is partial-ALPPS safer than ALPPS? A single-center experience [ J ]. Ann Surg, 2015,261 (4) :e90-92.
引证文献7
-
1王文青,吴刚,王雅玮,付雪岩,许绍林,刘永锋.三磷酸腺苷酶家族蛋白2在肝门部胆管癌中的表达及其临床意义[J].中华普通外科杂志,2019,34(1):58-61. 被引量:3
-
2陈英立.肝叶切除用于肝门胆管癌根治术的疗效观察[J].临床医药文献电子杂志,2015,2(8):1456-1456.
-
3鲁敏,秦兴雷,蔡建平,董亚东.89例肝门部胆管癌术后并发症分析[J].中华普通外科杂志,2015,30(7):535-537. 被引量:4
-
4洪德飞,沈国樑,张远标,范小明,罗祖炎,陈军法,成剑,黄东胜,彭淑牖.经皮微波消融肝实质分隔联合门静脉栓塞计划性肝切除治疗肝门部胆管癌[J].中华普通外科杂志,2016,31(9):750-753. 被引量:10
-
5葛金年,葛春林.扩大肝切除术治疗Ⅲ~Ⅳ型肝门胆管癌患者的效果及预后分析[J].中国医药指南,2017,15(6):152-153. 被引量:2
-
6张雷,王林,耿智敏,万永,孟凡迪,孟宪魁.肝叶切除与肝门胆管癌根治术联合应用的临床价值研究[J].中国现代手术学杂志,2017,21(1):5-8. 被引量:4
-
7黄庆国,朱载阳,李鹏泽.扩大肝切除术治疗Ⅲ至Ⅳ期肝门胆管癌的临床价值[J].癌症进展,2017,15(3):325-327. 被引量:3
二级引证文献25
-
1温志坚,陈战,闫兴洲,杨平华,林茜,刘理军,张宝华.三维可视化技术在Bismuth-Corlette Ⅲ、Ⅳ型肝门部胆管癌计划性肝切除中的应用[J].武警医学,2021(3):218-223. 被引量:9
-
2孙柳君,张琼,鲍映雪.健康教育联合心理干预对腔镜下胆管癌根治术患者的护理影响[J].浙江临床医学,2019,21(5):694-695.
-
3徐青松.经皮肝胆管穿刺引流在肝门部胆管癌中的应用[J].医学信息,2017,30(14):76-77.
-
4朱宇潇,王骥,马红钦,刘利,赵文星.完全腹腔镜下肝门部胆管癌根治术14例经验总结[J].中国普外基础与临床杂志,2019,26(1):56-60. 被引量:8
-
5赵学林,公婷,林洪峰,杜福田.联合肝脏分割和门静脉结扎的二步肝切除术后肝再生的研究进展[J].中华普通外科杂志,2019,34(2):187-189. 被引量:1
-
6李斌,姜小清.在“计划性肝切除”的理念下审视联合肝脏分隔和门静脉结扎的二步肝切除术及门静脉栓塞[J].临床外科杂志,2017,25(6):414-416. 被引量:4
-
7胡丹.护理干预对胆管癌合并糖尿病围术期患者血糖控制及并发症的效果[J].实用临床医药杂志,2017,21(16):62-64. 被引量:8
-
8李景林,姜兴明,冷开明,崔云甫.肝门部胆管癌肝切除范围的变化[J].中华普通外科杂志,2017,32(12):1077-1079. 被引量:4
-
9刘文师,刘婷婷,孙光为,富大智.两种肝切除手术在肝门胆管癌患者的应用和比较[J].中国继续医学教育,2018,10(7):100-103. 被引量:4
-
10冯霞,卞红艳,夏燕,吴瑶娟.肝硬化肝癌行PALPP的围术期心理干预[J].浙江临床医学,2018,20(6):1137-1138. 被引量:3
-
1李建军,卢榜裕,蔡小勇,黄玉斌,黄飞,靳小建,晏益核.腹腔镜治疗肝门胆管癌三例[J].中华外科杂志,2013,51(5):478-479. 被引量:4
-
2侯波,王志峰,陈星.晚期胆管癌外科手术治疗和内镜姑息治疗疗效观察[J].中华消化内镜杂志,2013,30(2):99-101. 被引量:2
-
3龙海,张雷.肝门区胆管癌的外科手术治疗新进展[J].中国医师进修杂志(外科版),2006,29(7):71-72. 被引量:1
-
4裘丰,王韦华,沈迎春,周新华,严志龙,陆才德.肝门胆管癌根治术9例报告[J].浙江临床医学,2005,7(4):373-373.
-
5张新霞.3D CT成像、MR 3D-VIBE等序列对肝门胆管癌的诊断价值[J].中国医疗前沿,2009,4(14):78-79. 被引量:3
-
6蔡敬铭.高位胆管癌38例诊治体会[J].广西医学,2003,25(11):2250-2251. 被引量:2
-
7江德全,冯华国,游宇来,谭孝华.肝门部胆管癌的诊治[J].中国现代普通外科进展,2012,15(3):222-224. 被引量:8
-
8黄国民,乔士兴,房学东,刘林林.肝门部胆管癌姑息性手术治疗体会[J].肝胆外科杂志,2009,17(2):120-122. 被引量:7
-
9周欣,黄志勇(综述),陈孝平(审校).肝移植治疗肝门部胆管癌[J].中华肝胆外科杂志,2007,13(7):499-502. 被引量:1
-
10陈雨信,徐克森,牛军,寿楠海.肝门部胆管癌的诊断和外科手术治疗[J].中国现代普通外科进展,2009,12(11):921-924. 被引量:2